[Surgical treatment of tricuspid regurgitation associated with left valvular heart disease: about 162 cases].

Pan Afr Med J

Service de Chirurgie Cardio-Vasculaire, CHU Hassan II Fès, Université Sidi Mohamed Ben Abdallah, Faculté de Médecine, de Pharmacie et de Médecine Dentaire, Fès, Morocco.

Published: March 2022

Tricuspid regurgitation (TR) is a prognostic factor associated with the outcome of patients undergoing surgical treatment of left valvular heart disease. The purpose of this study was to evaluate the postoperative outcome of patients with tricuspid regurgitation associated with left valvular heart disease and to identify factors associated with surgical failure. We conducted a retrospective study of 162 patients over the period January 2009 to July 2019. The study included all patients undergoing surgical treatment of TR and left valve repair. The average age of patients was 39.70 years ± 10.8, with a female predominance. We performed 47 (29%) tricuspid prosthetic annuloplasties, 103 (63.5%) De Vega´s annuloplasties and 12 (7.5%) posterior ring reductions or replacements out of 162 tricuspid valve repairs. Patients´ outcome was marked by clear improvement in morphological and functional echocardiographic parameter means. Surgical failure was reported in 24 (14.8%) patients. Four patients died within 30 postoperative days, reflecting a hospital mortality rate of 2.46%. The causes of death were refractory right ventricular failure (2 cases), and severe left ventricular failure (2 cases). Factors related to failure of tricuspid repair were: severe pre-operative tricuspid failure, postoperative pulmonary hypertension (> 60mmHg) and preoperative RV/LV ratio > 0.6. The results of this study provide a better understanding of the outcomes of patients undergoing surgical treatment of tricuspid failure and provide information on the indications for surgery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856983PMC
http://dx.doi.org/10.11604/pamj.2021.40.259.24146DOI Listing

Publication Analysis

Top Keywords

tricuspid regurgitation
12
left valvular
12
valvular heart
12
heart disease
12
patients undergoing
12
undergoing surgical
12
surgical treatment
12
tricuspid
8
treatment tricuspid
8
regurgitation associated
8

Similar Publications

Predictive value of CT-based and AI-reconstructed 3D-TAPSE in patients undergoing transcatheter tricuspid valve repair.

Front Cardiovasc Med

January 2025

Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum, NRW, Ruhr-Universität Bochum, Medizinische Fakultät OWL (Universität Bielefeld), Bad Oeynhausen, Germany.

Background: The tricuspid annular plane systolic excursion (TAPSE) assessed by echocardiography has failed in predicting outcomes in patients with severe tricuspid regurgitation (TR) undergoing transcatheter tricuspid valve intervention (TTVI). Considering the complex shape of the tricuspid annulus and right ventricle, as well as the difficult echocardiographic image acquisition of the right heart, cardiac computed tomography (CT) might be superior for the analysis of the annular excursion. Thus, this study aimed to analyze whether CT-captured TAPSE provides additional value in predicting outcomes after TTVI.

View Article and Find Full Text PDF

Objectives: The Ross procedure for aortic regurgitation (AR) and abnormal aortic valve morphologies is associated with an increased risk of autograft dilatation. Autograft support may ameliorate this problem. We analyzed the results for all haemodynamic lesions and the effect of autograft support.

View Article and Find Full Text PDF

Background And Aims: The association between periprocedural change in tricuspid regurgitation (TR) and outcomes in patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) is unclear. This study aimed to examine the prognostic value of TR before and after M-TEER.

Methods: Patients in the OCEAN-Mitral registry were divided into four groups according to baseline and post-procedure echocardiographic assessments: no TR/no TR (no TR), no TR/significant TR (new-onset TR), significant TR/no TR (normalized TR), and significant TR/significant TR (residual TR) (all represents before/after M-TEER).

View Article and Find Full Text PDF

Rediscovering racial disparities in tricuspid regurgitation: A call for increased and targeted treatment approach.

Int J Cardiol

January 2025

Department of Medical and Surgical Sciences - DIMEC - Alma Mater Studiorum, University of Bologna, Bologna, Italy; Cardiology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, 40138 Bologna, Italy.

View Article and Find Full Text PDF

This case details the successful implantation of a leadless pacemaker following the extraction of transvenous leads in a 72-year-old female patient with a complex cardiovascular history. The patient had undergone a series of cardiac interventions, including a recent percutaneous tricuspid valve repair with a metal clip implant due to severe regurgitation. After presenting with an infection at the pacemaker site, methicillin-resistant Staphylococcus hominis was identified, necessitating the removal of the entire pacing system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!